INT248772

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.39
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 5.16
Pain Relevance 0.19

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (CSF2) extracellular region (CSF2)
Anatomy Link Frequency
granulocyte 2
thickening 2
CSF2 (Homo sapiens)
Pain Link Frequency Relevance Heat
drug abuse 1 71.40 Quite High
Inflammation 34 71.08 Quite High
intrathecal 10 65.60 Quite High
Central nervous system 52 56.68 Quite High
tolerance 6 46.36 Quite Low
Pain 8 38.32 Quite Low
imagery 2 29.08 Quite Low
cytokine 12 5.00 Very Low Very Low Very Low
Dopamine 10 5.00 Very Low Very Low Very Low
Tetrahydrobiopterin 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Monosomy 14 100.00 Very High Very High Very High
Myeloid Leukemia 9 99.96 Very High Very High Very High
Leukemia 8 99.86 Very High Very High Very High
Dementia 69 99.64 Very High Very High Very High
Body Weight 2 99.44 Very High Very High Very High
Glycogen Storage Disease 7 98.92 Very High Very High Very High
Inflammatory Bowel Disease 24 98.78 Very High Very High Very High
Parkinson's Disease 155 98.36 Very High Very High Very High
Disease 201 98.16 Very High Very High Very High
Confusion 1 92.80 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Furthermore, in another animal model of IBD (rats treated with 2,4,6-trinitrobenzene sulfonic acid) the pretreatment with G-CSF attenuated both loss of body weight and colonic wall thickening (Egi et al 2003), and this effect was associated with a significant inhibition of IFN?
Negative_regulation (attenuated) of G-CSF Binding (pretreatment) of in thickening associated with inflammatory bowel disease and body weight
1) Confidence 0.39 Published 2008 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2621411 Disease Relevance 1.00 Pain Relevance 0.07
ratios improves the diagnostic CSF test accuracy for the dementia differential diagnosis, which is not the case when sole measurements of A?
Negative_regulation (improves) of CSF Binding (accuracy) of associated with dementia
2) Confidence 0.31 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 1.89 Pain Relevance 0
His CSF neopterin decreased rapidly, then more gradually, reaching 6.4 nmol/L at the end of follow up.
Negative_regulation (decreased) of CSF Binding (neopterin) of
3) Confidence 0.30 Published 2010 Journal AIDS Res Ther Section Body Doc Link PMC2890504 Disease Relevance 0.71 Pain Relevance 0.12
A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): A case report

Introduction

Negative_regulation (bearing) of G-CSF Binding (treatment) of in granulocyte associated with monosomy, leukemia, myeloid leukemia and glycogen storage disease
4) Confidence 0.25 Published 2008 Journal J Med Case Reports Section Title Doc Link PMC2566578 Disease Relevance 1.57 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox